instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'LEVETIRACETAM'? | An unusual case of neutrocytic, culture-negative meningitis in an immunocompetent adult.
Patient presenting with fever, acute onset seizure and neck stiffness on examination; deteriorating despite initiation of early treatment for meningitis.
Case report
A 62-year-old retired businessman from Thrissur district of Kera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 34035930 | 19,968,562 | 2021-05 |
What was the dosage of drug 'RIFAMPIN'? | An unusual case of neutrocytic, culture-negative meningitis in an immunocompetent adult.
Patient presenting with fever, acute onset seizure and neck stiffness on examination; deteriorating despite initiation of early treatment for meningitis.
Case report
A 62-year-old retired businessman from Thrissur district of Kera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 34035930 | 19,968,562 | 2021-05 |
What was the dosage of drug 'VANCOMYCIN'? | An unusual case of neutrocytic, culture-negative meningitis in an immunocompetent adult.
Patient presenting with fever, acute onset seizure and neck stiffness on examination; deteriorating despite initiation of early treatment for meningitis.
Case report
A 62-year-old retired businessman from Thrissur district of Kera... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 34035930 | 19,968,562 | 2021-05 |
What was the outcome of reaction 'Drug ineffective'? | An unusual case of neutrocytic, culture-negative meningitis in an immunocompetent adult.
Patient presenting with fever, acute onset seizure and neck stiffness on examination; deteriorating despite initiation of early treatment for meningitis.
Case report
A 62-year-old retired businessman from Thrissur district of Kera... | Fatal | ReactionOutcome | CC BY-NC | 34035930 | 20,197,337 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiogenic shock'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coxsackie viral infection'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ejection fraction decreased'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterovirus myocarditis'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypogammaglobulinaemia'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial oedema'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocarditis'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,385,000 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular tachycardia'. | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
What was the administration route of drug 'RITUXIMAB'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34035954 | 19,385,000 | 2021-03 |
What was the outcome of reaction 'Cardiac arrest'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Fatal | ReactionOutcome | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
What was the outcome of reaction 'Cardiogenic shock'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Fatal | ReactionOutcome | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
What was the outcome of reaction 'Coxsackie viral infection'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Fatal | ReactionOutcome | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
What was the outcome of reaction 'Ejection fraction decreased'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Fatal | ReactionOutcome | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
What was the outcome of reaction 'Enterovirus myocarditis'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Fatal | ReactionOutcome | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
What was the outcome of reaction 'Hypogammaglobulinaemia'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Fatal | ReactionOutcome | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
What was the outcome of reaction 'Myocardial oedema'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Fatal | ReactionOutcome | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
What was the outcome of reaction 'Myocarditis'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Fatal | ReactionOutcome | CC BY-NC | 34035954 | 19,385,000 | 2021-03 |
What was the outcome of reaction 'Ventricular tachycardia'? | Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a ge... | Fatal | ReactionOutcome | CC BY-NC | 34035954 | 19,417,657 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gas gangrene'. | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | PREDNISONE, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY | 34035966 | 19,410,733 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | PREDNISONE, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY | 34035966 | 19,410,733 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Splenic abscess'. | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | PREDNISONE, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY | 34035966 | 19,410,733 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Splenic necrosis'. | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | PREDNISONE, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY | 34035966 | 19,410,733 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 34035966 | 19,410,733 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 34035966 | 19,410,733 | 2021 |
What was the dosage of drug 'TACROLIMUS'? | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 34035966 | 19,410,733 | 2021 |
What was the outcome of reaction 'Clostridial infection'? | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | Recovered | ReactionOutcome | CC BY | 34035966 | 20,320,115 | 2021 |
What was the outcome of reaction 'Gas gangrene'? | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | Recovered | ReactionOutcome | CC BY | 34035966 | 19,410,733 | 2021 |
What was the outcome of reaction 'Splenic abscess'? | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | Recovered | ReactionOutcome | CC BY | 34035966 | 19,410,733 | 2021 |
What was the outcome of reaction 'Splenic necrosis'? | Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.
Clostridium perfringens is a rare cause of septic shock, occurring most frequently in immunocompromised patients. An uncommon cause of Clostridium perfringen septicemia is spontaneo... | Recovered | ReactionOutcome | CC BY | 34035966 | 19,410,733 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Parkinson^s disease'. | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | IVABRADINE | DrugsGivenReaction | CC BY | 34035985 | 19,794,440 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Postural orthostatic tachycardia syndrome'. | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | BUPROPION HYDROCHLORIDE, DOFETILIDE, DROXIDOPA, FLUDROCORTISONE ACETATE, IVABRADINE, MIDODRINE, MODAFINIL, NEBIVOLOL, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34035985 | 19,846,911 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus bradycardia'. | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | BUPROPION HYDROCHLORIDE, DOFETILIDE, DROXIDOPA, FLUDROCORTISONE ACETATE, IVABRADINE, MIDODRINE, MODAFINIL, NEBIVOLOL, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34035985 | 19,846,911 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus node dysfunction'. | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | BUPROPION HYDROCHLORIDE, DOFETILIDE, DROXIDOPA, FLUDROCORTISONE ACETATE, IVABRADINE, MIDODRINE, MODAFINIL, NEBIVOLOL, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34035985 | 19,846,911 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | BUPROPION HYDROCHLORIDE, DOFETILIDE, DROXIDOPA, FLUDROCORTISONE ACETATE, IVABRADINE, MIDODRINE, MODAFINIL, NEBIVOLOL, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34035985 | 19,846,911 | 2021-05 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34035985 | 19,789,304 | 2021-05 |
What was the administration route of drug 'UNSPECIFIED INGREDIENT'? | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34035985 | 19,846,911 | 2021-05 |
What was the outcome of reaction 'Postural orthostatic tachycardia syndrome'? | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | Recovering | ReactionOutcome | CC BY | 34035985 | 19,846,911 | 2021-05 |
What was the outcome of reaction 'Sinus bradycardia'? | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | Recovering | ReactionOutcome | CC BY | 34035985 | 19,846,911 | 2021-05 |
What was the outcome of reaction 'Sinus node dysfunction'? | Sick Sinus Syndrome Can Be Associated with Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia Syndrome.
As a known phenomenon, crossover between sinus node dysfunction and common atrial tachyarrhythmias-most notably, atrial fibrillation and atrial flutter-in older individuals has previously been seen. He... | Recovering | ReactionOutcome | CC BY | 34035985 | 19,846,911 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Autoimmune thyroiditis'. | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | APIXABAN, CARBOPLATIN, CISPLATIN, DACTINOMYCIN, ETOPOSIDE, HEPARIN SODIUM, METHOTREXATE, OXACILLIN SODIUM, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34036138 | 19,459,500 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | APIXABAN, CISPLATIN, DACTINOMYCIN, ETOPOSIDE, METHOTREXATE, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34036138 | 19,452,843 | 2021-05 |
What was the administration route of drug 'CISPLATIN'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34036138 | 19,443,884 | 2021-05 |
What was the administration route of drug 'DACTINOMYCIN'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34036138 | 19,432,426 | 2021-05 |
What was the administration route of drug 'ETOPOSIDE'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34036138 | 19,443,884 | 2021-05 |
What was the administration route of drug 'HEPARIN SODIUM'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34036138 | 19,432,426 | 2021-05 |
What was the administration route of drug 'METHOTREXATE'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34036138 | 19,432,426 | 2021-05 |
What was the administration route of drug 'OXACILLIN SODIUM'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34036138 | 19,432,426 | 2021-05 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Other | DrugAdministrationRoute | CC BY | 34036138 | 19,459,500 | 2021-05 |
What was the dosage of drug 'CARBOPLATIN'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | RECEIVED WITH CYCLE 10 | DrugDosageText | CC BY | 34036138 | 19,459,500 | 2021-05 |
What was the dosage of drug 'METHOTREXATE SODIUM'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | 2700 MG/M2, CYCLIC (FREQ:9 {CYCLICAL};DAY 9) | DrugDosageText | CC BY | 34036138 | 19,443,884 | 2021-05 |
What was the outcome of reaction 'Autoimmune thyroiditis'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Recovered | ReactionOutcome | CC BY | 34036138 | 19,459,500 | 2021-05 |
What was the outcome of reaction 'Ototoxicity'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Recovered | ReactionOutcome | CC BY | 34036138 | 19,443,884 | 2021-05 |
What was the outcome of reaction 'Thrombocytopenia'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Recovered | ReactionOutcome | CC BY | 34036138 | 19,443,884 | 2021-05 |
What was the outcome of reaction 'Tinnitus'? | Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.
Placental Site Trophoblastic Tumor (PSTT) is a rare malignancy that often presents with extensive disease and can be resistant to traditional treatmen... | Recovered | ReactionOutcome | CC BY | 34036138 | 19,443,884 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Antibody test positive'. | Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin.
IVIG is occasionally used for preventing and treating severe infections of patients who are to undergo transplantation. Administration of IVIG, which includes high-titer antibodies (Abs) agains... | ACYCLOVIR SODIUM, ALBUMIN HUMAN, CARPERITIDE, DEXMEDETOMIDINE HYDROCHLORIDE, FENTANYL CITRATE, HUMAN IMMUNOGLOBULIN G, HYDROCORTISONE SODIUM SUCCINATE, MEROPENEM, MORPHINE HYDROCHLORIDE, NAFAMOSTAT MESYLATE, NOREPINEPHRINE, PROPOFOL, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34036167 | 14,753,710 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transplant failure'. | Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin.
IVIG is occasionally used for preventing and treating severe infections of patients who are to undergo transplantation. Administration of IVIG, which includes high-titer antibodies (Abs) agains... | ACYCLOVIR SODIUM, ALBUMIN HUMAN, CARPERITIDE, DEXMEDETOMIDINE HYDROCHLORIDE, FENTANYL CITRATE, HUMAN IMMUNOGLOBULIN G, HYDROCORTISONE SODIUM SUCCINATE, MEROPENEM, MORPHINE HYDROCHLORIDE, NAFAMOSTAT MESYLATE, NOREPINEPHRINE, PROPOFOL, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34036167 | 14,753,710 | 2021-06 |
What is the weight of the patient? | Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin.
IVIG is occasionally used for preventing and treating severe infections of patients who are to undergo transplantation. Administration of IVIG, which includes high-titer antibodies (Abs) agains... | 72 kg. | Weight | CC BY-NC-ND | 34036167 | 14,753,710 | 2021-06 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin.
IVIG is occasionally used for preventing and treating severe infections of patients who are to undergo transplantation. Administration of IVIG, which includes high-titer antibodies (Abs) agains... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34036167 | 14,753,710 | 2021-06 |
What was the outcome of reaction 'Antibody test positive'? | Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin.
IVIG is occasionally used for preventing and treating severe infections of patients who are to undergo transplantation. Administration of IVIG, which includes high-titer antibodies (Abs) agains... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34036167 | 14,753,710 | 2021-06 |
What was the outcome of reaction 'Transplant failure'? | Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin.
IVIG is occasionally used for preventing and treating severe infections of patients who are to undergo transplantation. Administration of IVIG, which includes high-titer antibodies (Abs) agains... | Fatal | ReactionOutcome | CC BY-NC-ND | 34036167 | 14,753,710 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer.
OBJECTIVE
MET dysregulation is an oncogenic driver in non-small-cell lung cancer (NSCLC), as well as a mechanism of TKI (tyrosine kinase inhibitor) resistance in patients with epidermal growth factor receptor (EGFR)-... | CAPMATINIB, ERLOTINIB | DrugsGivenReaction | CC BY-NC-ND | 34036220 | 19,053,142 | 2021 |
What was the administration route of drug 'CAPMATINIB'? | Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer.
OBJECTIVE
MET dysregulation is an oncogenic driver in non-small-cell lung cancer (NSCLC), as well as a mechanism of TKI (tyrosine kinase inhibitor) resistance in patients with epidermal growth factor receptor (EGFR)-... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34036220 | 19,053,142 | 2021 |
What was the administration route of drug 'ERLOTINIB'? | Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer.
OBJECTIVE
MET dysregulation is an oncogenic driver in non-small-cell lung cancer (NSCLC), as well as a mechanism of TKI (tyrosine kinase inhibitor) resistance in patients with epidermal growth factor receptor (EGFR)-... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34036220 | 19,053,142 | 2021 |
What was the dosage of drug 'CAPMATINIB'? | Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer.
OBJECTIVE
MET dysregulation is an oncogenic driver in non-small-cell lung cancer (NSCLC), as well as a mechanism of TKI (tyrosine kinase inhibitor) resistance in patients with epidermal growth factor receptor (EGFR)-... | UNK, TAKEN EVERY 12 HOURS, IN CYCLES OF 28 DAYS | DrugDosageText | CC BY-NC-ND | 34036220 | 19,053,142 | 2021 |
What was the dosage of drug 'ERLOTINIB'? | Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer.
OBJECTIVE
MET dysregulation is an oncogenic driver in non-small-cell lung cancer (NSCLC), as well as a mechanism of TKI (tyrosine kinase inhibitor) resistance in patients with epidermal growth factor receptor (EGFR)-... | UNK UNK, QD, TAKEN DAILY | DrugDosageText | CC BY-NC-ND | 34036220 | 19,053,142 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Histiocytic sarcoma'. | Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.
OBJECTIVE
Anaplastic lymphoma kinase (ALK) rearrangement is a well-known driver oncogene in non-small-cell lung cancer and has also been identified in other types of tumors. However, there is limited evidence on the clinical response to ALK ... | CERITINIB | DrugsGivenReaction | CC BY | 34036223 | 20,834,553 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Inflammatory myofibroblastic tumour'. | Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.
OBJECTIVE
Anaplastic lymphoma kinase (ALK) rearrangement is a well-known driver oncogene in non-small-cell lung cancer and has also been identified in other types of tumors. However, there is limited evidence on the clinical response to ALK ... | CERITINIB | DrugsGivenReaction | CC BY | 34036223 | 20,834,575 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteosarcoma'. | Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.
OBJECTIVE
Anaplastic lymphoma kinase (ALK) rearrangement is a well-known driver oncogene in non-small-cell lung cancer and has also been identified in other types of tumors. However, there is limited evidence on the clinical response to ALK ... | EVEROLIMUS, SORAFENIB | DrugsGivenReaction | CC BY | 34036223 | 20,820,343 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.
OBJECTIVE
Anaplastic lymphoma kinase (ALK) rearrangement is a well-known driver oncogene in non-small-cell lung cancer and has also been identified in other types of tumors. However, there is limited evidence on the clinical response to ALK ... | EVEROLIMUS, SORAFENIB | DrugsGivenReaction | CC BY | 34036223 | 20,820,343 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Salivary gland neoplasm'. | Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.
OBJECTIVE
Anaplastic lymphoma kinase (ALK) rearrangement is a well-known driver oncogene in non-small-cell lung cancer and has also been identified in other types of tumors. However, there is limited evidence on the clinical response to ALK ... | CERITINIB | DrugsGivenReaction | CC BY | 34036223 | 20,834,861 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.
OBJECTIVE
Anaplastic lymphoma kinase (ALK) rearrangement is a well-known driver oncogene in non-small-cell lung cancer and has also been identified in other types of tumors. However, there is limited evidence on the clinical response to ALK ... | CERITINIB | DrugsGivenReaction | CC BY | 34036223 | 20,834,553 | 2021 |
What was the administration route of drug 'CERITINIB'? | Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.
OBJECTIVE
Anaplastic lymphoma kinase (ALK) rearrangement is a well-known driver oncogene in non-small-cell lung cancer and has also been identified in other types of tumors. However, there is limited evidence on the clinical response to ALK ... | Oral | DrugAdministrationRoute | CC BY | 34036223 | 20,834,861 | 2021 |
What was the administration route of drug 'EVEROLIMUS'? | Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.
OBJECTIVE
Anaplastic lymphoma kinase (ALK) rearrangement is a well-known driver oncogene in non-small-cell lung cancer and has also been identified in other types of tumors. However, there is limited evidence on the clinical response to ALK ... | Oral | DrugAdministrationRoute | CC BY | 34036223 | 20,820,343 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Procedural haemorrhage'. | Anaesthesia and orphan disease: management of a case of Nicolaides-Baraitser syndrome undergoing cleft palate surgery.
Nicolaides-Baraitser syndrome (NCBRS) is a rare disease caused by mutations in the SMRCA2 gene, which affects chromatin remodelling and leads to a wide range of symptoms including microcephaly, distinc... | CLONIDINE, DIPYRONE, FENTANYL, MIDAZOLAM, ROCURONIUM BROMIDE, SEVOFLURANE, XYLOMETAZOLINE | DrugsGivenReaction | CC BY | 34039274 | 20,257,666 | 2021-05-26 |
What is the weight of the patient? | Anaesthesia and orphan disease: management of a case of Nicolaides-Baraitser syndrome undergoing cleft palate surgery.
Nicolaides-Baraitser syndrome (NCBRS) is a rare disease caused by mutations in the SMRCA2 gene, which affects chromatin remodelling and leads to a wide range of symptoms including microcephaly, distinc... | 8 kg. | Weight | CC BY | 34039274 | 20,257,666 | 2021-05-26 |
What was the dosage of drug 'SEVOFLURANE'? | Anaesthesia and orphan disease: management of a case of Nicolaides-Baraitser syndrome undergoing cleft palate surgery.
Nicolaides-Baraitser syndrome (NCBRS) is a rare disease caused by mutations in the SMRCA2 gene, which affects chromatin remodelling and leads to a wide range of symptoms including microcephaly, distinc... | 6 VOL%. | DrugDosageText | CC BY | 34039274 | 20,257,666 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophageal fistula'. | Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma.
BACKGROUND
This retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and ... | CISPLATIN, DOCETAXEL, RADIATION THERAPY | DrugsGivenReaction | CC BY | 34039375 | 20,151,665 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia aspiration'. | Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma.
BACKGROUND
This retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and ... | CISPLATIN, DOCETAXEL, RADIATION THERAPY | DrugsGivenReaction | CC BY | 34039375 | 20,151,653 | 2021-05-26 |
What was the dosage of drug 'RADIATION THERAPY'? | Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma.
BACKGROUND
This retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and ... | TOTAL RADIATION DOSE OF 50?60 GY (MEDIAN DOSE 50.4 GY) GIVEN DAILY FRACTIONS OF 1.8-2.0 GY | DrugDosageText | CC BY | 34039375 | 20,151,665 | 2021-05-26 |
What was the outcome of reaction 'Oesophageal fistula'? | Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma.
BACKGROUND
This retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and ... | Fatal | ReactionOutcome | CC BY | 34039375 | 20,151,665 | 2021-05-26 |
What was the outcome of reaction 'Pneumonia aspiration'? | Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma.
BACKGROUND
This retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and ... | Fatal | ReactionOutcome | CC BY | 34039375 | 20,151,653 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A 61-year-old woman with jejunal lymphatic malformation visualized on computed tomography: a case report.
BACKGROUND
Jejunal lymphatic malformations are congenital lesions that are seldom diagnosed in adults and rarely seen on imaging.
METHODS
A 61-year-old Caucasian woman was initially diagnosed and treated for muci... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34039402 | 20,137,829 | 2021-05-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Felty syndrome: a case report.
BACKGROUND
Felty syndrome is a rare manifestation of chronic rheumatoid arthritis in which patients develop extraarticular features of hepatosplenomegaly and neutropenia. The typical presentation of Felty syndrome is in Caucasians, females, and patients with long-standing rheumatoid arthr... | AMOXICILLIN, AZITHROMYCIN ANHYDROUS, CEFUROXIME, DOXYCYCLINE | DrugsGivenReaction | CC BY | 34039422 | 19,476,887 | 2021-05-27 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | Felty syndrome: a case report.
BACKGROUND
Felty syndrome is a rare manifestation of chronic rheumatoid arthritis in which patients develop extraarticular features of hepatosplenomegaly and neutropenia. The typical presentation of Felty syndrome is in Caucasians, females, and patients with long-standing rheumatoid arthr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34039422 | 19,476,887 | 2021-05-27 |
What was the administration route of drug 'AZITHROMYCIN'? | Felty syndrome: a case report.
BACKGROUND
Felty syndrome is a rare manifestation of chronic rheumatoid arthritis in which patients develop extraarticular features of hepatosplenomegaly and neutropenia. The typical presentation of Felty syndrome is in Caucasians, females, and patients with long-standing rheumatoid arthr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34039422 | 20,135,663 | 2021-05-27 |
What was the administration route of drug 'CEFUROXIME'? | Felty syndrome: a case report.
BACKGROUND
Felty syndrome is a rare manifestation of chronic rheumatoid arthritis in which patients develop extraarticular features of hepatosplenomegaly and neutropenia. The typical presentation of Felty syndrome is in Caucasians, females, and patients with long-standing rheumatoid arthr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34039422 | 19,476,887 | 2021-05-27 |
What was the outcome of reaction 'Drug hypersensitivity'? | Felty syndrome: a case report.
BACKGROUND
Felty syndrome is a rare manifestation of chronic rheumatoid arthritis in which patients develop extraarticular features of hepatosplenomegaly and neutropenia. The typical presentation of Felty syndrome is in Caucasians, females, and patients with long-standing rheumatoid arthr... | Recovered | ReactionOutcome | CC BY | 34039422 | 20,135,663 | 2021-05-27 |
What was the outcome of reaction 'Neutropenia'? | Felty syndrome: a case report.
BACKGROUND
Felty syndrome is a rare manifestation of chronic rheumatoid arthritis in which patients develop extraarticular features of hepatosplenomegaly and neutropenia. The typical presentation of Felty syndrome is in Caucasians, females, and patients with long-standing rheumatoid arthr... | Recovered | ReactionOutcome | CC BY | 34039422 | 19,432,852 | 2021-05-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Affective disorder'. | Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy.
We report the case of letrozole-induced radiation recall dermatitis (RRD) in a patient with a remote history of radiation therapy. There is only one previously known case of RRD triggered by letrozole i... | LETROZOLE | DrugsGivenReaction | CC BY | 34039983 | 19,412,592 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alopecia'. | Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy.
We report the case of letrozole-induced radiation recall dermatitis (RRD) in a patient with a remote history of radiation therapy. There is only one previously known case of RRD triggered by letrozole i... | LETROZOLE | DrugsGivenReaction | CC BY | 34039983 | 20,870,158 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cellulitis'. | Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy.
We report the case of letrozole-induced radiation recall dermatitis (RRD) in a patient with a remote history of radiation therapy. There is only one previously known case of RRD triggered by letrozole i... | LETROZOLE | DrugsGivenReaction | CC BY | 34039983 | 19,412,592 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depression'. | Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy.
We report the case of letrozole-induced radiation recall dermatitis (RRD) in a patient with a remote history of radiation therapy. There is only one previously known case of RRD triggered by letrozole i... | LETROZOLE | DrugsGivenReaction | CC BY | 34039983 | 20,870,158 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy.
We report the case of letrozole-induced radiation recall dermatitis (RRD) in a patient with a remote history of radiation therapy. There is only one previously known case of RRD triggered by letrozole i... | LETROZOLE | DrugsGivenReaction | CC BY | 34039983 | 20,870,158 | 2021-05-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | Radiation recall dermatitis following letrozole administration in patient with a remote history of radiation therapy.
We report the case of letrozole-induced radiation recall dermatitis (RRD) in a patient with a remote history of radiation therapy. There is only one previously known case of RRD triggered by letrozole i... | LETROZOLE | DrugsGivenReaction | CC BY | 34039983 | 20,870,158 | 2021-05-26 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.